Department of Microbiology, University College of Medical Sciences & Guru Tegh Bahadur Hospital & *

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Department of Microbiology, University College of Medical Sciences & Guru Tegh Bahadur Hospital & *"

Transcription

1 Indian J Med Res 122, October 2005, pp Phenotypic characteristics of clinical isolates of Klebsiella pneumoniae & evaluation of available phenotypic techniques for detection of extended spectrum beta-lactamases Vikas Manchanda, N.P. Singh, R. Goyal, A. Kumar & S.S. Thukral * Department of Microbiology, University College of Medical Sciences & Guru Tegh Bahadur Hospital & * V.P. Chest Institute, University of Delhi, Delhi, India Received August 12, 2004 Background & objectives: Identifying organisms that harbour extended spectrum beta lactamases (ESBLs) is a major challenge for a diagnostic clinical microbiology laboratory. Wide variety of ESBLs produced and lack of a sensitive phenotypic method for their detection make the detection of ESBLs difficult and is responsible for under-recognition. The present study was undertaken to evaluate phenotypic characteristics, initial screening tests and established confirmatory phenotypic methods for detection of ESBLs Klebsiella pneumoniae isolates prevalent in a hospital in north India. Methods: One hundred, non-repeat clinical isolates of K. pneumoniae collected over a period of six months were included in the study. Susceptibilities of the isolates to 20 different antimicrobial agents were determined. Agar dilution and broth dilution methods were used to determine minimum inhibitory concentrations (MICs) of ceftazidime (CAZ) and cefotaxime (CTX). CAZ and CTX were used with and without clavulanic acid to detect ESBL harbouring isolates. Using agar dilution and broth dilution, MIC reduction of two and three doubling dilutions were evaluated as a criterion for ESBL harbouring isolates. Standard double disk synergy test (DDST) with disks placed at 30mm and modified DDST with disks placed at 16mm center-to-center distance, using at least two different third generation cephalosporins and combined disk method were also performed to detect ESBL harbouring isolates. Results: Multi-drug resistance (resistance to three or more antimicrobials of different classes) was found among 94 per cent of the isolates. Pooling the results of all the three confirmatory techniques MIC reduction of > 3 doubling dilutions using broth dilution method (using CTX and CAZ), combined disk method [(using CTX, ceftriaxone [(CRO), CAZ and aztreonam)] and standard DDST (using CTX, CRO, CAZ and aztreonam), revealed as many as 87 per cent of the isolates as ESBL producers. CTX had greater sensitivity in identifying isolates that harboured ESBLs. Modified DDST using CTX was as sensitive method as broth dilution method and combined disk method in detecting ESBL harbouring isolates. MIC reduction technique using agar dilution method and standard DDST had lowest overall sensitivity in detecting ESBLs. Interpretation & conclusion: Modified DDST using at least two different third generation cephalosporins was considered to be the best technique for detection of ESBL producing K. pneumoniae at our hospital. MIC reduction test with > 2 doubling dilution reduction in MICs was found to be a better criterion than the presently recommended > 3 doubling dilution reduction. For screening of potential ESBL producers, MIC determination using agar dilution was as good as that using broth dilution method. However, while performing MIC reduction test agar dilution method was found highly unreliable for detection of ESBL harbouring isolates. Key words Double disk synergy test - ESBLs - K. pneumoniae - MIC reduction test 330

2 MANCHANDA et al : PHENOTYPIC TECHNIQUES FOR DETECTION OF ESBLs 331 Despite the fact that there are large numbers of Gram negative clinical isolates that harbour extended spectrum beta lactamases (ESBLs), very few clinical laboratories routinely perform ESBL detection, especially in developing countries, due to costs involved, work load and extra labour. Efforts have been made for detection and interpretation of ESBLs among clinical isolates and various cut off points of disk diffusion and minimum inhibitory concentrations (MICs) have been described 1-3. A key problem in the detection of ESBL producers is the possibility of low level expression of enzyme and of inoculum effect, resulting in variable MIC values and zone diameters by disk diffusion testing. Although different enzymes of TEM- and SHV- class show some patterns in antibiogram, the enzymes differ in the level of resistance conferred to different antimicrobial compounds. Therefore, specific detection methods such as the double disk synergy test (DDST), combined disk method, E-test and three-dimensional methods have been described 1,4-6. Different studies have reported greater sensitivity or reliability of detection of one method over the other as well as the success of particular antimicrobial substrates. Of these methods, it is still impractical to use E test for detection of ESBLs on routine basis in diagnostic laboratories because of forbidden cost in developing countries. Moreover, difficulty in interpretation of E test has been reported in some cases due to 'phantom effect' 7,8. Threedimensional test is still evolving 9. In an earlier study different phenotypic techniques using well-characterised ESBL harbouring isolates have been compared and the investigators have emphasized to extend similar studies to the various clinical isolates 8. Detection rates for a particular method generally vary with the types of ESBLs produced and the geographical area where these clinical isolates are prevalent. Therefore, standardization of the techniques needs to be done to exploit the method for maximal detection of ESBL producers without false positive or negative results. Many studies from India have reported occurrence of ESBLs in various members of Enterobacteriaceae using different phenotypic methods The present study was carried out to evaluate phenotypic characteristics of clinical isolates of Klebsiella pneumoniae in a tertiary care hospital in north India and to determine the best phenotypic technique for detection of ESBLs among the clinical isolates. Material & Methods One hundred consecutive, non-repeat clinical isolates of K. pneumoniae obtained from various clinical specimens sent to microbiology laboratory at University College of Medical Sciences and Guru Tegh Bahadur Hospital, Delhi during March and August 2001 were included in the study. The isolates were identified with standard biotyping methods 20. Of these neonatal intensive care unit (NICU) contributed to 19 isolates, and 31 isolates each were recovered from wound swabs from burns unit, and samples from various sites in patients admitted to inpatient units. Samples from outpatients contributed 18 isolates. One isolate was recovered from a patient in ICU. Antimicrobial susceptibilities of the isolates to 20 different antimicrobial agents (µg) viz. cefoperazone, (75) ceftazidime (CAZ), (30) cefotaxime (CTX) (30) aztreonam (ATM) (30) ceftriaxone (CRO) (30) cefepime, (30), cefoxitin (30), cefotetan, (30) cotrimoxazole (1.25/23.75) amikacin, (30) gentamicin, (10) kanamycin, (30) ciprofloxacin, (5) chloramphenicol, (30) pipracillin, (100) pipracillin + tazobactam, (100/10) amoxycillin + clavulanate, (20/10), loracarbef (30) imipenem (10) and netilmicin (30) were determined by standard disk diffusion (SDD) using commercially available disks (Oxoid, Basingstoke, UK) and were categorized as sensitive, intermediate and resistant as per National Committee for Clinical Laboratory Standards (NCCLS) guidelines wherever applicable 1. Quality control was achieved by using standard strain of Escherichia coli ATCC NCCLS recommendations to identify potential ESBL producing isolates using standard disk diffusion technique were followed, i.e., zone sizes of < 22mm, < 27mm, < 27mm and < 25mm for CAZ, ATM, CTX and CRO respectively, were taken to identify potential ESBL harbouring isolates 1. MICs of CAZ and CTX for these isolates were determined by the agar dilution and broth dilution methods using series of dilutions containing the antimicrobial (CAZ or CTX) alone (final concentrations

3 332 INDIAN J MED RES, OCTOBER 2005 of mg/ml), and with 4mg/ml clavulanic acid (CA; Ranbaxy, India). MIC cut-off points for ESBL producers were taken according to the NCCLS recommendations, isolates with MICs > 2mg/ml for CAZ, and MICs > 8mg/ml for CTX were identified as potential ESBL producers 1. The MIC reduction of two times and three times doubling dilutions were assessed for cut-off to be taken as ESBL phenotype. Standard and modified double disk synergy test (DDST) was performed using disks of 30 mg each of CAZ and CTX along with AMCA (amoxycillin 20 mg x clavulanic acid 10 mg). The disks were placed at the distance 30 and 16 mm from each other (centre to centre) and incubated at 37 0 C overnight 12. The organism was considered habouring ESBLs if the zone of inhibition around the CAZ and/or CTX disk showed a clear cut increase towards the AMCA disk 4,12. Combined disk method was used as recommended by the NCCLS 1. One disk each of CAZ/CA (30 /10mg) and CTX/CA (30/10mg) were applied to the surface of the inoculated plate. A disk each of CAZ and CTX were also applied. A 5mm increase in zone diameter for either antimicrobial agent tested in combination with CA versus its zone when tested alone was taken as an indication of ESBL producing isolates. Quality control was achieved using E. coli ATCC and K. pneumoniae ATCC Criteria for confirmed ESBL phenotype: When the isolate was found to harbour ESBL by atleast two of the three confirmatory criteria that included MIC reduction of > 3 doubling dilutions using broth dilution method (using CTX and CAZ), combined disk method (using CTX, CRO and CAZ), and DDST (using CTX, CRO and CAZ) with 30 mm distance center-to-center between the two disks, it was labeled as confirmed ESBL phenotype. Results & Discussion All the isolates were found susceptible to imipenem (Table I). Multi drug resistance (resistance to three or more antimicrobials of different classes) was found among 94 per cent of the isolates. Six isolates that were not multi drug resistant were all ESBL non-producers. Also, 59 of the total isolates were resistant to all the tested third generation cephalosporins (3GC) and aztreonam. Among non-beta-lactam agents, chloramphenicol and co-trimoxazole were the two antimicrobials against which maximum ESBL harbouring isolates were found susceptible (Table II). Susceptibility to aminoglycosides was found low among the ESBL producers ranging between 6-20 per cent. Among all the isolates studied 37.9 per cent were found resistant to the piperacillin+tazobactam combination while all isolates were found susceptible to carbapenems studied. The reasons for this pattern are not known. None of the ESBL harbouring isolates was sensitive to combination of amoxycillin and clavulanic acid (Table II). An association was found between aztreonam and gentamcin resistance and ESBL production. Isolates that were resistant to gentamicin and aztreonam harboured ESBLs but not all the ESBL harbouring isolates were resistant to the two antimicrobials. No other association between antimicrobial susceptibility and ESBL production could be identified. Using standard disk diffusion (SDD) as screening method for identifying potential ESBL producers, ceftriaxone was the most efficient antimicrobial in screening isolates as potential ESBL producers followed by CTX (Table III). Ceftriaxone missed three ESBL harbouring isolates. Cefotaxime and aztreonam missed seven and nine ESBL harbouring isolates respectively. Ceftazidime was the least efficient among these four antimicrobials missing 14 isolates that were later identified as harbouring ESBLs. MICs determined using agar dilution and broth dilution methods revealed similar results. The detailed distribution of MICs of the isolates for ceftazidime and cefotaxime is shown in Fig.1 and 2. Among ESBL harbouring isolates MICs of <2mg/ml was found in nine isolates for CAZ and MICs of < 8mg/ml was observed in five of these isolates for CTX Minimum inhibitory concentrations of < 1mg/ml was observed among four ESBL producing isolates (one isolate for CTX and three isolates for CAZ). ESBL producing K. pneumoniae may have higher MICs against antimicrobials compared with those of ESBL non-producing isolates. Since these elevated MICs to CAZ do not reach the NCCLS recommended break point levels for potential ESBL producers

4 MANCHANDA et al : PHENOTYPIC TECHNIQUES FOR DETECTION OF ESBLs 333 (>2mg/ml), therefore, such isolates may be incorrectly dismissed as ESBL non-producing isolates 1. The isolates having high MICs of oxyimino beta-lactam agents can be labeled as potential ESBL producers. In the present study, nine isolates could not meet the NCCLS criteria for potential ESBL producers. Moreover, MICs of four ESBL harbouring isolates were < 1 mg/ml. Some other workers have also reported similar findings 22,23. It has been shown that amino acid substitutions in Klebsiella ESBLs can results in such MIC changes. However, none of the Indian studies has reported ESBL producing K. pneumoniae with MICs of < 2 mg/ml 13,14. Therefore, great caution is needed in interpreting the MICs cut-off for ESBL harbouring isolates. Using MIC reduction test as confirmatory test for detection of ESBL producing isolates, with > 3 doubling dilution MIC reduction criterion for ESBL producers, CTX detected greater number of ESBL harbouring isolates than CAZ. However, use of > 2 doubling dilution MIC reduction criterion increased the sensitivity of detection of ESBL harbouring isolates (Table IV). The extra isolates that were detected by modified criterion (> 2 doubling dilution MICs reduction) were also confirmed as harbouring ESBLs using combined disk method and standard double disk synergy test. When standard DDST (30mm distance center-tocenter) was used as confirmatory test for detection of ESBL producing isolates, maximum of 22 isolates were detected as ESBL producers using CRO. However, reducing the distance to 16mm center-to-center markedly increased the sensitivity of the test (Table IV). CTX and CRO detected maximum number of ESBL harbouring isolates followed by aztreonam and ceftazidime. The results obtained by the combined disk method revealed similar results CTX and CRO were better antimicrobials for detection of ESBL harbouring isolates than aztreonam and CAZ. Pooling the results of all the three confirmatory techniques MIC reduction of > 3 doubling dilutions using broth dilution method (using CTX and CAZ), combined disk method (using CTX, CRO, CAZ and aztreonam), and DDST (using CTX, CRO, CAZ and aztreonam) with 30 mm distance center-to-center Table I. Antimicrobial susceptibility profiles of all Klebsiella pneumoniae isolates included in the study Drug No. of isolates Sensitive Intermediate Resistant Amikacin Amoxycillin + Clavulanate Aztreonam Cefepime Cefoperazone Cefotaxime Cefotetan Cefoxitin Ceftazidime Ceftriaxone Chloramphenicol Ciprofloxacin Cotrimoxazole Gentamicin Imipenem Kanamycin Loracarbef Netilmicin Piperacillin Piperacillin + Tazobactam

5 334 INDIAN J MED RES, OCTOBER 2005 between the two disks, revealed as many as per 87 per cent of the isolates as ESBL producers. CTX had greater sensitivity in identifying isolates that harboured ESBLs. Modified DDST using CTX was as sensitive as broth dilution method and combined disk method in detecting ESBL harbouring isolates. MIC reduction technique using agar dilution method and standard DDST (30mm distance center-to-center) had lowest overall sensitivity in detecting ESBLs. The distance between disks is critical for each enzyme, as the test depends on the concentration of both beta-lactam antibiotic and inhibitor. Several attempts may be required to detect an ESBL producer. Several modifications, including the choice of drugs tested and varying the distance between the disks, have been recommended 4-6. We tried different distances viz., 30, 20, 16 and 14mm for detection of ESBL harbouring isolates. Best results were obtained by using at 16mm distance center-to-center between the two disks (unpublished data). Increasing the distance further between the two disks resulted in missing a large number of ESBL harbouring isolates. On the other hand, decreasing the distance further interfered with the interpretation of the results. A study from India also used 16 mm distance and reported good results 12. Several workers from India and other countries have used 30, 25, 21 and 20mm distance between the disks and few have labeled the method as inadequate for detecting all the ESBL producing isolates 4,5,11,24,25. In the present study, use of cefotaxime and ceftriaxone in the DDST resulted in the detection of a larger number of ESBLs harbouring isolates than ceftazidime. The results were similar to the combined disk method currently recommended by the NCCLS. Thus, for laboratories that perform susceptibility testing by disk diffusion, modified DDST could be easily incorporated into an already existing system. It has the added benefit that there is no need to measure zone sizes hence removing the subjectivity and is easy to read by recording presence or absence of synergy. Further, it requires no extra time in setting up the test and reading it. MIC reduction of > 2 or > 4 fold has been used in the past 6,14,26. It is important to note that three additional isolates identified by using > 2 doubling dilution Table II. Susceptibility profiles of extended spectrum b-lactamase (ESBL) producing Klebsiella pneumoniae Drug Sensitive Intermediate Resistant n (%) n (%) n (%) Amikacin 16 (18.3) 5 (5.7) 66 (75.8) Amoxycillin + Clavulanate (100) Aztreonam 13 (14.9) 12 (13.7) 62 (71.2) Cefepime 42 (48.2) 25 (28.0) 20 (22.9) Cefoperazone 13 (14.9) 1(0.01) 73 (83.9) Cefotaxime 14 (16.0) 10 (11.4) 63 (72.4) Cefotetan 69 (79.3) 0 18 (20.6) Cefoxitin 51 (58.6) 10 (11.4) 16 (18.3) Ceftazidime 21 (24.1) 07 (08.0) 59 (67.8) Ceftriaxone 10 (11.4) 13 (14.9) 64 (73.5) Chloramphenicol 40 (45.9) 4 (04.5) 43 (49.4) Ciprofloxacin 17 (19.5) 7 (8.0) 63 (72.4) Co-trimoxazole 25 (28.0) 13 (14.9) 49 (56.3) Gentamicin 17 (19.5) 0 70 (80.4) Imipenem 87 (100) 0 0 Kanamycin 5 (5.7) 0 82 (94.2) Loracarbef 51 (58.6) 31 (35.6) 5 (5.7) Netilmicin 25 (28.7) 0 62 (71.2) Piperacillin (100) Piperacillin + Tazobactam 12 (13.7) 42 (48.2) 33 (37.9)

6 MANCHANDA et al : PHENOTYPIC TECHNIQUES FOR DETECTION OF ESBLs 335 Minimum inhibitory concentration (mg/ml) Fig.1. Minimum inhibitory concentrations (MICs) distribution of cefotaxime among all the clinical isolates of K. pneumoniae included in the study. Minimum inhibitory concentration (mg/ml) Fig.2. Minimum inhibitory concentrations (MICs) distribution of ceftazidime among all the clinical isolates of K. pneumoniae included in the study. reduction criterion were later confirmed by standard DDST and combined disk method as ESBL producers. Further studies are needed to confirm these findings. Our findings showed that modified DDST has an added advantage over the combined method since it is easier to perform and quick to interpret. In our study, the modified DDST was found as good as MIC reduction test using broth dilution in detection of ESBL producers. A study from Turkey has reported MIC reduction as a better technique than standard DDST for the detection of ESBL harbouring isolates 27. Table III. Comparison of methods used for screening and identification of extended spectrum b-lactamases (ESBLs) MIC reduction DDST Antimicrobials SDD MIC* > 2 doubling > 3 fold doubling Combined for dilutions dilutions disk method screening Agar Broth Agar Broth 16 mm 30 mm dilution dilution dilution dilution Cefotaxime (> 8mg/ml) Ceftazidime (> 2 mg/ml) Ceftriaxone 84 ND ND ND ND ND Aztreonam 78 ND ND ND ND ND *MICs determined using agar and broth dilution produced exactly similar results for CTX and CAZ ND, not determined; SDD, standard disk diffusion; MIC, minimum inhibitory concentration, DDST, double disk synergy test. All figures are in percentages

7 336 INDIAN J MED RES, OCTOBER 2005 Table IV. Sensitivities of extended spectrum b-lactamase (ESBL) confirmatory tests for different antimicrobials MIC reduction Antimicrobials > 2 doubling > 3 fold doubling DDST Combined dilutions dilutions disk method Agar Broth Agar Broth 16 mm 30 mm dilution dilution dilution dilution Cefotaxime Ceftazidime Ceftriaxone ND ND ND ND Aztreonam ND ND ND ND ND, not determined. Other abbreviations same as in Table III. All figures are in percentages Sensitivity of particular test using an antimicrobial was calculated using number of isolates identified as ESBL producer using that particular method and antimicrobial divided by total number of ESBL harbouring isolates that were identified using three standard method It was observed that when used alone, CAZ was able to detect lesser number of the ESBL producing isolates as compared to CTX by all the three confirmatory techniques. Combination of two or more techniques increased the detection rate of ESBL producers. It is important to note that for screening of potential ESBL producers MIC determination using broth dilution was as good as that using agar dilution method. However, while performing MIC reduction test agar dilution method was found highly unreliable for detection of ESBL harbouring isolates. The material, labour and cost involved may preclude the use of MIC reduction test for detection of ESBL harbouring isolates in routine clinical laboratories. To conclude, modified DDST using at least two different 3GCs was the best technique for detection of ESBL producing K. pneumoniae at our hospital. MIC reduction test with > 2 doubling dilution reduction in MICs was found to be a better criterion than the presently recommended > 3 doubling dilution reduction. Our observations suggested that additional testing to detect ESBL production in the clinical isolates on a routine basis, would be necessary to institute appropriate antibiotic therapy. References 1. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 10th Informational Supplement, Wayne, Pennsylvania: National Committee for Clinical Laboratory Standards Document M100-S10; D' Agata E, Venkataraman L, DeGirolami P, Weigel L, Samore M, Tenovar F. The molecular and clinical epidemiology of enterobacteriaceae-producing extendedspectrum beta-lactamase in a tertiary care hospital J Infect 1998; 36 : Dandekar PK, Barrett NL, Nightingale CH, Nicolau DP. Utilization of extended-spectrum beta-lactamase (ESBL) detection systems in microbiology laboratories: survey of Connecticut hospitals from Conn Med 2003; 67 : Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10 : Thomson KS, Sanders CC. Detection of extended spectrum beta-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests. Antimicrob Agents Chemother 1992; 36 : Cormican MG, Marshall SA, Jones RN. Detection of extendedspectrum beta-lactamase (ESBL)-producing strains by the E test ESBL screen. J Clin Microbiol 1996; 34 : Bradford PA. Extended spectrum beta-lactamases in the 21st century: characterisation, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14 : MacKenzie FM, Miller CA, Gould IM. Comparison of screening methods for TEM- and SHV- derived extended - spectrum beta-lactamase detection. Clin Microbiol Infect 2002; 8 : Manchanda V, Singh NP. Occurrence and detection of AmpC beta-lactamases among Gram-negative clinical isolates using a modified three-dimensional test at Guru Tegh Bahadur

8 MANCHANDA et al : PHENOTYPIC TECHNIQUES FOR DETECTION OF ESBLs 337 Hospital, Delhi, India. J Antimicrob Chemother 2003; 51 : Jain A, Roy I, Gupta MK, Kumar M, Agarwal SK. Prevalence of extended-spectrum beta-lactamase-producing Gram-negative bacteria in septicaemic neonates in a tertiary care hospital. J Med Microbiol 2003; Subha A, Ananthan S. Extended spectrum beta-lactamase mediated resistance to third generation cephalosporins among Klebsiella pneumoniae in Chennai. Indian J Med Microbiol 2002; 20 : Ananthakrishanan AN, Kanungo R, Kumar A, Badrinath S. Detection of extended spectrum beta-lactamase producers among surgical wound infectons and burns patiens in JIPMER. Indian J Med Microbiol 2000; 18 : Hansotia JB, Agarwal V, Pathak AA, Saoji A M. Extended spectrum beta-lactamase mediated resistance to third generation cephalosporins in Klebsiella pneumoniae in Nagpur, central India. Indian J Med Res 1997; 105 : Abigail S, Mathai E, Jesudason MV, John TJ. Ceftazidime resistance among Klebsiella pneumoniae in south India Indian J Med Res 1995; 102 : Shukla I, Tiwari R, Agrawal M. Prevalence of extended spectrum beta-lactamase producing Klebsiella pneumoniae in a tertiary care hospital Indian J Med Microbiol 2004; 22 : Revathi G, Singh S, Singh S. Detection of expanded spectrum cephalosporin resistance due to inducible lactamases in hospital isolates. Indian J Med Microbiol 1997; 15 : Mathur P, Kapil A, Das B, Dhawan B. Prevalence of extended spectrum beta lactamase producing Gram negative bacteria in a tertiary care hospital. Indian J Med Res 2002; 115 : Khurana S, Taneja N, Sharma M. Extended spectrum betalactamase mediated resistance in urinary tract isolates of family Enterobacteriaceae. Indian J Med Res 2002; 116 : Shahid M, Malik A, Agrawal M, Singhal S. Phenotypic detection of extended-spectrum and AmpC beta-lactamases by a new spot-inculation method and modified three-dimensional extract test: comparison with the conventional threedimensional extract test J Antimicrob Chemother 2004; 54 : Crichton PB. Enterobacteriaceae: Escherichia, Klebsiella, Proteus and other genera. In: Collee, I G, Fraser A G, Marmion, B P, Simmons A, editors. Mackie & McCartney practical medical microbiology, 14th ed. Edinburgh, UK: Churchill Livingstone, 1996; p Jorgensen JH, Turnidge JD. Susceptibility testing methods: Dilution and disk diffusion methods. In: Murray PR, Baron EJ, Pfaller MA, Jorgenson JH, Yolken RH, editors. Manual of clinical microbiology, 8th ed VA, USA: ASM Press 2003; p West PW. Extended spectrum beta-lactamase producing Klebsiella spp. Br J Biomed Sci 2000; 57 : Yuan M, Aucken H, Hall LM, Pitt TL, Livermore DM. Epidemiological typing of klebsiellae with extended-spectrum beta-lactamases from European intensive care units. J Antimicrob Chemother 1998; 41 : Emery CL, Weymouth LA. Detection and clinical significance of extended-spectrum b-lactamases in a tertiary-care medical center. J Clin Microbiol 1997; 35 : Coudron PE, Moland ES, Sanders CC. Occurrence and detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a Veterans medical center: seek and you may find. J Clin Microbiol 1997; 35 : Ho PL, Chow KH, Yuen KY, Ng WS, Chau PY. Comparison of a novel, inhibitor-potentiated disk-diffusion test with other methods for the detection of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae. J Antimicrob Chemother 1998; 42 : Kocazeybek BS. Antimicrobial resistance surveillance of Gramnegative isolated from intensive care units of four different hospitals in Turkey. Evaluation of the prevalence of extendedspectrum and inducible beta-lactamases using different E-test strips and direct induction methods. Chemotherapy 2001; 47 : Reprint requests: Dr N.P. Singh, Department of Microbiology, University College of Medical Science & Guru Tegh Bahadur Hospital Dilshad Garden, Delhi , India

IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 10 Ver. VII (Oct. 2017), PP 76-81 www.iosrjournals.org Molecular Characterization of TEM, SHV

More information

Evaluation of a 12 Disc Test for Phenotypic Detection of β- lactamases Resistance in Gram Negative Bacilli

Evaluation of a 12 Disc Test for Phenotypic Detection of β- lactamases Resistance in Gram Negative Bacilli International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 5 Number 6 (2016) pp. 105-114 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2016.506.013

More information

Original article DOI: Journal of International Medicine and Dentistry 2016; 3(1): 34-41

Original article DOI:  Journal of International Medicine and Dentistry 2016; 3(1): 34-41 Original article DOI: http://dx.doi.org/10.18320/jimd/201603.0134 JOURNAL OF INTERNATIONAL MEDICINE AND DENTISTRY To search..to know...to share p-issn: 2454-8847 e-issn: 2350-045X Comparative analysis

More information

The biomérieux solution. VITEK2 : A challenge with ESBL ESBL. Karen Bush

The biomérieux solution. VITEK2 : A challenge with ESBL ESBL. Karen Bush International Newsletter n 4 December 2003 Through the IDENTIFYING RESISTANCE Newsletter, biomérieux s ambition is to contribute to the awareness and progress in the field of resistance to antibiotics.

More information

Detection and molecular characterization of extended spectrum of beta lactamase (ESBL) producing Escherichia coli

Detection and molecular characterization of extended spectrum of beta lactamase (ESBL) producing Escherichia coli ISSN: 2319-7706 Volume 2 Number 8 (2013) pp. 196-205 http://www.ijcmas.com Original Research Article Detection and molecular characterization of extended spectrum of beta lactamase (ESBL) producing Escherichia

More information

Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype

Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype J Antimicrob Chemother 2010; 65: 460 464 doi:10.1093/jac/dkp484 Advance publication 22 January 2010 Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC

More information

International Journal of Current Research in Medical Sciences

International Journal of Current Research in Medical Sciences Int. J. Curr. Res. Med. Sci. (2016). 2(1): 1 10 International Journal of Current Research in Medical Sciences ISSN: 2454-5716 www.ijcrims.com Coden: IJCRPP(USA) Research Article http://s-o-i.org/1.15/ijcrms-2016-2-1-1

More information

H. Wu, B.-G. Liu, J.-H. Liu, Y.-S. Pan, L. Yuan and G.-Z. Hu

H. Wu, B.-G. Liu, J.-H. Liu, Y.-S. Pan, L. Yuan and G.-Z. Hu Phenotypic and molecular characterization of CTX-M-14 extended-spectrum β-lactamase and plasmid-mediated ACT-like AmpC β-lactamase produced by Klebsiella pneumoniae isolates from chickens in Henan Province,

More information

The occurrence of AmpC β-lactamase and ESBL producing Gram-negative bacteria by a simple..

The occurrence of AmpC β-lactamase and ESBL producing Gram-negative bacteria by a simple.. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 14, Issue 12 Ver. I (Dec. 2015), PP 19-24 www.iosrjournals.org The occurrence of AmpC β-lactamase and

More information

Chapter 9 Antimicrobial Susceptibility Testing (Agar Disk Diffusion Method)

Chapter 9 Antimicrobial Susceptibility Testing (Agar Disk Diffusion Method) Chapter 9 Antimicrobial Susceptibility Testing (Agar Disk Diffusion Method) The disk diffusion method presented in this chapter has been carefully standardized by the National Committee for Clinical Laboratory

More information

JOURNAL OF INTERNATIONAL ACADEMIC RESEARCH FOR MULTIDISCIPLINARY Impact Factor 1.393, ISSN: , Volume 2, Issue 8, September 2014

JOURNAL OF INTERNATIONAL ACADEMIC RESEARCH FOR MULTIDISCIPLINARY Impact Factor 1.393, ISSN: , Volume 2, Issue 8, September 2014 EVALUATION OF CHROMAGAR-CTX FOR THE DETECTION OF CTX-M-ESBL- PRODUCING GRAM NEGATIVE BACTERIAL ISOLATES RASHA H. ELSHERIF* LAMIAA A. MADKOUR** REHAM A. DWEDAR*** *Clinical Pathology Department, Faculty

More information

Characterization, Antibiotic Resistance Pattern and Detection of Metalloβ-lactamases and Amp C in Pseudomonas aeruginosa in a Tertiary Care Hospital

Characterization, Antibiotic Resistance Pattern and Detection of Metalloβ-lactamases and Amp C in Pseudomonas aeruginosa in a Tertiary Care Hospital Original Research Characterization, Antibiotic Resistance Pattern and Detection of Metalloβ-lactamases and Amp C in Pseudomonas aeruginosa in a Tertiary Care Hospital Amit Rajshekar Ugargol 1, Shilpa Karnum

More information

Extended-spectrum b-lactamases of Escherichia coli and Klebsiella pneumoniae screened by the VITEK 2 system

Extended-spectrum b-lactamases of Escherichia coli and Klebsiella pneumoniae screened by the VITEK 2 system Journal of Medical Microbiology (2011), 60, 756 760 DOI 10.1099/jmm.0.024075-0 Extended-spectrum b-lactamases of Escherichia coli and Klebsiella pneumoniae screened by the VITEK 2 system Maria José Espinar,

More information

A Verification Study for Implementing the Revised CLSI Breakpoints. Summary. Breakpoint Differences Cephalosporin Breakpoints for Enterobacteriaceae

A Verification Study for Implementing the Revised CLSI Breakpoints. Summary. Breakpoint Differences Cephalosporin Breakpoints for Enterobacteriaceae A Verification Study for Implementing the Revised CLSI Breakpoints Jean B. Patel, PhD, D(ABMM) Deputy Director, Office of Antimicrobial Resistance National Center for Emerging and Zoonotic Infectious Disease

More information

A Verification Study for Implementing the Revised CLSI Breakpoints. Summary. Glossary CDC 1

A Verification Study for Implementing the Revised CLSI Breakpoints. Summary. Glossary CDC 1 A Verification Study for Implementing the Revised CLSI Breakpoints Jean B. Patel, PhD, D(ABMM) Deputy Director, Office of Antimicrobial Resistance National Center for Emerging and Zoonotic Infectious Disease

More information

The Prevalence of TEM-1 gene causing resistance to beta-lactam antibiotics in Klebsiella pneumoniae isolates from clinical samples and plasmid curing

The Prevalence of TEM-1 gene causing resistance to beta-lactam antibiotics in Klebsiella pneumoniae isolates from clinical samples and plasmid curing Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2016, 5, 11:557-561 The Prevalence of TEM-1 gene causing resistance to beta-lactam antibiotics

More information

Title: Description of the First Escherichia coli Clinical Isolate Harboring Colistin-

Title: Description of the First Escherichia coli Clinical Isolate Harboring Colistin- AAC Accepted Manuscript Posted Online 24 October 2016 Antimicrob. Agents Chemother. doi:10.1128/aac.01945-16 Copyright 2016, American Society for Microbiology. All Rights Reserved. 1 2 Title: Description

More information

OXA-type beta-lactamases among extended-spectrum cephalosporin-resistant Pseudomonas aeruginosa isolates in a university hospital in southern Taiwan

OXA-type beta-lactamases among extended-spectrum cephalosporin-resistant Pseudomonas aeruginosa isolates in a university hospital in southern Taiwan OXA-type J Microbiol ESBLs Immunol in P. Infect aeruginosa 2006;39:130-134 OXA-type beta-lactamases among extended-spectrum cephalosporin-resistant Pseudomonas aeruginosa isolates in a university hospital

More information

Ongoing epidemic of bla VIM-1 -positive Klebsiella pneumoniae in Athens, Greece: a prospective survey

Ongoing epidemic of bla VIM-1 -positive Klebsiella pneumoniae in Athens, Greece: a prospective survey Journal of Antimicrobial Chemotherapy (2008) 61, 59 63 doi:10.1093/jac/dkm443 Advance Access publication 13 November 2007 Ongoing epidemic of bla VIM-1 -positive Klebsiella pneumoniae in Athens, Greece:

More information

Variable susceptibility to piperacillin/tazobactam amongst Klebsiella spp. with extended-spectrum β-lactamases

Variable susceptibility to piperacillin/tazobactam amongst Klebsiella spp. with extended-spectrum β-lactamases Journal of Antimicrobial Chemotherapy (2003) 51, 605 612 DOI: 10.1093/jac/dkg114 Advance Access publication 28 January 2003 Variable susceptibility to piperacillin/tazobactam amongst Klebsiella spp. with

More information

New Delhi metallo-β-lactamase - type carbapenemases producing Escherichia coli isolates from hospitalized patients: A pilot study

New Delhi metallo-β-lactamase - type carbapenemases producing Escherichia coli isolates from hospitalized patients: A pilot study Indian J Med Res 146, July 2017, pp 105-110 DOI: 10.4103/ijmr.IJMR_594_15 Quick Response Code: New Delhi metallo-β-lactamase - type carbapenemases producing Escherichia coli isolates from hospitalized

More information

Extended-Spectrum β-lactamases Producing Escherichia coli Strains Monitored Over 4 Years in The University Hospital in Košice, Slovakia

Extended-Spectrum β-lactamases Producing Escherichia coli Strains Monitored Over 4 Years in The University Hospital in Košice, Slovakia Current Research in Microbiology Original Research Paper Extended-Spectrum β-lactamases Producing Escherichia coli Strains Monitored Over 4 Years in The University Hospital in Košice, Slovakia 1 Viera

More information

Received 6 July 2004; returned 14 August 2004; revised 6 September 2004; accepted 8 September 2004

Received 6 July 2004; returned 14 August 2004; revised 6 September 2004; accepted 8 September 2004 Journal of Antimicrobial Chemotherapy (2004) 54, 870 875 DOI: 10.1093/jac/dkh449 Advance Access publication 7 October 2004 Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum

More information

Verification of Disk Diffusion Tests

Verification of Disk Diffusion Tests Verification of Disk Diffusion Tests Objectives 1. Describe disk diffusion tests 2. Describe process of FDA clearance of susceptibility tests 3. Discuss CLIA requirements for laboratory verification of

More information

Evaluation of the Osiris Expert System for Identification of -Lactam Phenotypes in Isolates of Pseudomonas aeruginosa

Evaluation of the Osiris Expert System for Identification of -Lactam Phenotypes in Isolates of Pseudomonas aeruginosa JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 2003, p. 3712 3718 Vol. 41, No. 8 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.8.3712 3718.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.

More information

Combatting AMR: diagnostics

Combatting AMR: diagnostics Combatting AMR: diagnostics Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit Crown copyright Gonorrhoea: a paradigm for better diagnostics International

More information

ANTIMICROBIAL SUSCEPTIBILITY TESTING: ADVANCED

ANTIMICROBIAL SUSCEPTIBILITY TESTING: ADVANCED ANTIMICROBIAL SUSCEPTIBILITY TESTING: ADVANCED Romney Humphries, Ph.D., DABMM Section Chief, Clinical Microbiology University of California Los Angeles Lost Angeles, CA Susan E. Sharp, Ph.D., DABMM, FAAM

More information

Ezy MIC Strip FEATURES AND ADVANTAGES

Ezy MIC Strip FEATURES AND ADVANTAGES Imipenem with & without EDTA Ezy MIC Strips (IPM+EDTA/IPM) (Imipenem + EDTA: 1-64 mcg/ml) (Imipenem : 4-256 mcg/ml) Antimicrobial Susceptibility Testing For In Vitro Diagnostic use EM078 Not for Medicinal

More information

Evaluation of a Double Synergy Differential Test (DSDT) for differential detection of ESBL and AmpC-type

Evaluation of a Double Synergy Differential Test (DSDT) for differential detection of ESBL and AmpC-type NEW MICROBIOLOGICA, 35, 221-225, 2012 Evaluation of a Double Synergy Differential Test (DSDT) for differential detection of ESBL and AmpC-type β-lactamases in Escherichia coli, Klebsiella pneumoniae and

More information

Verification of Gradient Diffusion Strips

Verification of Gradient Diffusion Strips Verification of Gradient Diffusion Strips Objectives 1. Describe gradient diffusion tests 2. Describe process of FDA clearance of susceptibility tests 3. Discuss CLIA requirements for laboratory verification

More information

Biofilm Protocol Optimization For Pseudomonas aeruginosa. Introduction. Materials and Methods. Culture Media, Incubation Time, and Biofilm Measurement

Biofilm Protocol Optimization For Pseudomonas aeruginosa. Introduction. Materials and Methods. Culture Media, Incubation Time, and Biofilm Measurement Biofilm Protocol Optimization For Pseudomonas aeruginosa Culture Media, Incubation Time, and Biofilm Measurement Introduction In addition to the conventional arsenal of antibiotic resistance mechanisms

More information

Key words: Extended spectrum β-lactamase (ESBL), Double Disk Synergy Test (DDST), Antibiogram, Plasmid, PCR

Key words: Extended spectrum β-lactamase (ESBL), Double Disk Synergy Test (DDST), Antibiogram, Plasmid, PCR DOI: 10.7860/JCDR/2013/6460.3462 Microbiology Section Original Article Prevalence and antibiogram of Extended Spectrum β-lactamase (ESBL) producing Gram negative bacilli and further molecular characterization

More information

CRE is not the first organism we ve had that has become resistant to antibiotics, so why is it so important? CRE resistance is complex because it can

CRE is not the first organism we ve had that has become resistant to antibiotics, so why is it so important? CRE resistance is complex because it can 1 Enterobacteriaceae are a large family of bacteria that are a normal part of a person's digestive system (2). Examples include Escherichia coli and species of the genera Klebsiella, Enterobacter, Serratia,

More information

ABC. Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline. Volume 19 Number 18

ABC. Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline. Volume 19 Number 18 M26-A ISBN 1-56238-384-1 September 1999 ISSN 0273-3099 Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline Volume 19 Number 18 Arthur L. Barry, Ph.D. William A. Craig,

More information

J. Appl. Environ. Biol. Sci., 5(12) , , TextRoad Publication

J. Appl. Environ. Biol. Sci., 5(12) , , TextRoad Publication J. Appl. Environ. Biol. Sci., 5(2)262-268, 205 205, TextRoad Publication ISSN: 2090-4274 Journal of Applied Environmental and Biological Sciences www.textroad.com Study of routine antibiotic Resistance

More information

International Journal of Pharma and Bio Sciences STUDIES ON EFFECT OF CEFOTAXIME AND TERMINALIA CHEBULA ON ESCHERICHIA COLI ABSTRACT

International Journal of Pharma and Bio Sciences STUDIES ON EFFECT OF CEFOTAXIME AND TERMINALIA CHEBULA ON ESCHERICHIA COLI ABSTRACT Research Article Microbiology International Journal of Pharma and Bio Sciences ISSN 0975-6299 STUDIES ON EFFECT OF CEFOTAXIME AND TERMINALIA CHEBULA ON ESCHERICHIA COLI ALPA RABADIA *, S.D. KAMAT AND D.V.

More information

Extended-spectrum and CMY-type b-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain

Extended-spectrum and CMY-type b-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain ORIGINAL ARTICLE 10.1111/j.1469-0691.2009.03001.x Extended-spectrum and CMY-type b-lactamase-producing Escherichia coli in clinical samples and retail meat from, USA and, Spain Y. Doi 1, D. L. Paterson

More information

Plasmids-Mediated Antibiotic Resistance in E. coli

Plasmids-Mediated Antibiotic Resistance in E. coli Plasmids-Mediated Antibiotic Resistance in E. coli (Received: 08.12.1998) Nariman A. H. Aly*; Amany Tharwat** and Wesam F. El-Baz** *Microbial Genetics Dept., Genetic Engineering and Biotechnology Div.,

More information

Validation of the Automated Reading and Incubation System with Sensititre Plates for Antimicrobial Susceptibility Testing

Validation of the Automated Reading and Incubation System with Sensititre Plates for Antimicrobial Susceptibility Testing JOURNAL OF CLINICAL MICROBIOLOGY, May 2003, p. 1951 1956 Vol. 41, No. 5 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.5.1951 1956.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.

More information

BD BBL CHROMagar CPE

BD BBL CHROMagar CPE INSTRUCTIONS FOR USE READY-TO-USE PLATED MEDIA BD BBL CHROMagar CPE PA- 257681.02 Rev. January 2017 INTENDED USE BD BBL CHROMagar CPE is a selective chromogenic screening medium for the detection of carbapenemase

More information

Raymond G. Batchoun, Samer F. Swedan, and Abdullah M. Shurman. 1. Introduction

Raymond G. Batchoun, Samer F. Swedan, and Abdullah M. Shurman. 1. Introduction Hindawi Publishing Corporation International Journal of Microbiology Volume 2009, Article ID 513874, 8 pages doi:10.1155/2009/513874 Research Article ExtendedSpectrumβ-Lactamases among Gram-Negative Bacterial

More information

Ampicillin-Sulbactam and Amoxicillin-Clavulanate Susceptibility Testing of Escherichia coli Isolates with Different -Lactam Resistance Phenotypes

Ampicillin-Sulbactam and Amoxicillin-Clavulanate Susceptibility Testing of Escherichia coli Isolates with Different -Lactam Resistance Phenotypes ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 1999, p. 862 867 Vol. 43, No. 4 0066-4804/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Ampicillin-Sulbactam and Amoxicillin-Clavulanate

More information

Meropenem: in-vitro activity and kinetics of activity against organisms of the Bacteroides fragilis group

Meropenem: in-vitro activity and kinetics of activity against organisms of the Bacteroides fragilis group Journal of Antimicrobial Chemotherapy (99) 7, 599-606 Meropenem: in-vitro activity and kinetics of activity against organisms of the Bacteroides fragilis group J. A. Garcia-Rodriguez, J. E. Garcia Sanchez,

More information

MICROBIOLOGY LETTERS. Introduction RESEARCH LETTER

MICROBIOLOGY LETTERS. Introduction RESEARCH LETTER RESEARCH LETTER Predominant characteristics of CTX-M-producing Klebsiella pneumoniae isolates from patients with lower respiratory tract infection in multiple medical centers in China Shuchang An 1, Jichao

More information

Molecular investigation of extendedspectrum beta-lactamase genes and potential drug resistance in clinical isolates of Morganella morganii

Molecular investigation of extendedspectrum beta-lactamase genes and potential drug resistance in clinical isolates of Morganella morganii Molecular investigation of extendedspectrum beta-lactamase genes and potential drug resistance in clinical isolates of Morganella morganii Abbas S. Al-Muhanna, a Sddiq Al-Muhanna, a Maytham A. Alzuhairi

More information

Supplementary Information for

Supplementary Information for Supplementary Information for Direct, rapid antimicrobial susceptibility test from positive blood cultures based on microscopic imaging analysis J. Choi 1, H. Y. Jeong 2,3, G. Y. Lee 2,4, S. Han 1, S.

More information

Abstract. Introduction

Abstract. Introduction ORIGINAL ARTICLE BACTERIOLOGY A sensitive and specific phenotypic assay for detection of metallo-blactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic

More information

THE USE OF SEKISUI DIAGNOSTICS PENICILLINASE

THE USE OF SEKISUI DIAGNOSTICS PENICILLINASE THE USE OF SEKISUI DIAGNOSTICS PENICILLINASE AND β-lactamase PRODUCTS INTRODUCTION The aim of this guide is to outline the general procedures for the use of Sekisui Diagnostics Penicillinase and β-lactamase

More information

Relationship between Adhesion to Intestinal Caco-2 Cells and Multidrug Resistance in Klebsiella pneumoniae Clinical Isolates

Relationship between Adhesion to Intestinal Caco-2 Cells and Multidrug Resistance in Klebsiella pneumoniae Clinical Isolates JOURNAL OF CLINICAL MICROBIOLOGY, June 1997, p. 1499 1503 Vol. 35, No. 6 0095-1137/97/$04.00 0 Copyright 1997, American Society for Microbiology Relationship between Adhesion to Intestinal Caco-2 Cells

More information

Received 24 June 2008/Returned for modification 12 August 2008/Accepted 14 September 2008

Received 24 June 2008/Returned for modification 12 August 2008/Accepted 14 September 2008 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Dec. 2008, p. 4268 4273 Vol. 52, No. 12 0066-4804/08/$08.00 0 doi:10.1128/aac.00830-08 Copyright 2008, American Society for Microbiology. All Rights Reserved. High

More information

Detection of Plasmid-Mediated AmpC Beta-Lactamases in Clinically Significant Bacterial Isolates in a Research Institute Hospital in Egypt

Detection of Plasmid-Mediated AmpC Beta-Lactamases in Clinically Significant Bacterial Isolates in a Research Institute Hospital in Egypt Detection of Plasmid-Mediated AmpC Beta-Lactamases in Clinically Significant Bacterial Isolates in a Research Institute Hospital in Egypt Nevine Fam 1, Doaa Gamal 1, Manal El Said 1, Laila Aboul-Fadl 1,

More information

Cloning and Characterization of E. meningoseptica Beta Lactamase

Cloning and Characterization of E. meningoseptica Beta Lactamase Cloning and Characterization of E. meningoseptica Beta Lactamase Authors: Lindsey Purcell, Jessica Matts, Patricia Canaan* Department of Biochemistry and Molecular Biology Abstract Elizabethkingia meningoseptica

More information

NCCLS Standards for Antimicrobial Susceptibility Tests

NCCLS Standards for Antimicrobial Susceptibility Tests CE Update Microbiology III NCCLS Standards for Antimicrobial Susceptibility Tests Clyde Thornsberry, PhD T he most requested test of the clinical microbiology laboratory today is probably t h e antimicrobial

More information

Molecular Characterization of Bla CTX-M, Bla TEM, Bla SHV- eta Lactamase Produced by Uropathogenic Escherichia coli Isolates

Molecular Characterization of Bla CTX-M, Bla TEM, Bla SHV- eta Lactamase Produced by Uropathogenic Escherichia coli Isolates International Journal of Microbiological Research 6 (2): 67-73, 2015 ISSN 2079-2093 IDOSI Publications, 2015 DOI: 10.5829/idosi.ijmr.2015.6.2.9399 Molecular Characterization of Bla CTX-M, Bla TEM, Bla

More information

ACCEPTED. Variant CTX-M-59 in a Neonatal Intensive Care Unit in. Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh,

ACCEPTED. Variant CTX-M-59 in a Neonatal Intensive Care Unit in. Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, AAC Accepts, published online ahead of print on 1 March 00 Antimicrob. Agents Chemother. doi:./aac.0-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights

More information

Developing Novel Antibacterials to Treat Multi-drug Resistant Gram-negative Bacterial Infections. 13 th Needham Healthcare Conference April 8, 2014

Developing Novel Antibacterials to Treat Multi-drug Resistant Gram-negative Bacterial Infections. 13 th Needham Healthcare Conference April 8, 2014 Developing Novel Antibacterials to Treat Multi-drug Resistant Gram-negative Bacterial Infections 13 th Needham Healthcare Conference April 8, 2014 Forward Looking Statements Forward-Looking Statements

More information

NosocomialTransmission of CTX-M-15 and OXA-30 β-lactamase-producing Escherichia coli in a Neurosurgical Intensive Care Unit

NosocomialTransmission of CTX-M-15 and OXA-30 β-lactamase-producing Escherichia coli in a Neurosurgical Intensive Care Unit Available online at www.annclinlabsci.org 297 NosocomialTransmission of CTX-M-15 and OXA-30 β-lactamase-producing Escherichia coli in a Neurosurgical Intensive Care Unit Yang-Ree Kim, 1 Sang-Il Kim, 1

More information

Determination of Penicillin MICs for Streptococcus pneumoniae by Using a Two- or Three-Disk Diffusion Procedure

Determination of Penicillin MICs for Streptococcus pneumoniae by Using a Two- or Three-Disk Diffusion Procedure JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 1998, p. 179 183 Vol. 36, No. 1 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology Determination of Penicillin MICs for Streptococcus pneumoniae

More information

Prevalence of bla TEM, bla SHV and bla CTX-M among β-lactamase producing Escherichia coli isolated from tertiary care hospitals in Taif, Saudi Arabia

Prevalence of bla TEM, bla SHV and bla CTX-M among β-lactamase producing Escherichia coli isolated from tertiary care hospitals in Taif, Saudi Arabia IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS) e-issn:2278-3008, p-issn:2319-7676. Volume 12, Issue 1 Ver. III (Jan. - Feb.2017), PP 11-16 www.iosrjournals.org Prevalence of bla TEM, bla

More information

Prevalence of Klebsiella pneumoniae Carbapenemase (KPC), Metallo Beta Lactamases and AmpC beta Lactamases in Clinical Isolates of Klebsiella Species

Prevalence of Klebsiella pneumoniae Carbapenemase (KPC), Metallo Beta Lactamases and AmpC beta Lactamases in Clinical Isolates of Klebsiella Species ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 170-176 http://www.ijcmas.com Original Research Article Prevalence of Klebsiella pneumoniae Carbapenemase (KPC), Metallo Beta Lactamases and AmpC beta Lactamases

More information

Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole

Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole J Microbiol Immunol Infect. 2009;42:148-153 Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole Sai-Cheong

More information

Effect of the growth of anaerobic bacteria on the surface ph of solid media

Effect of the growth of anaerobic bacteria on the surface ph of solid media J Clin Pathol 185;38:565-56 Effect of the growth of anaerobic bacteria on the surface ph of solid media BRIAN WATT, FIONA V BROWN From the Department of Bacteriology, City Hospital, Edinburgh SUMMARY Changes

More information

Received 30 October 2003/Returned for modification 28 January 2004/Accepted 14 April 2004

Received 30 October 2003/Returned for modification 28 January 2004/Accepted 14 April 2004 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 2004, p. 3086 3092 Vol. 48, No. 8 0066-4804/04/$08.00 0 DOI: 10.1128/AAC.48.8.3086 3092.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.

More information

Standard Operating Procedure

Standard Operating Procedure Subject Vitek 2 Compact Identification and Susceptibility Testing Index Number Lab-1512 Section Laboratory Subsection Regional Clinic / Affiliate Hospital Laboratories Category Departmental Contact Sanders,

More information

International Journal of Pharma and Bio Sciences PHENOTYPIC DETECTION OF METALLO BETA LACTAMASE PRODUCING PSEUDOMONAS AERUGINOSA IN WOUNDS ABSTRACT

International Journal of Pharma and Bio Sciences PHENOTYPIC DETECTION OF METALLO BETA LACTAMASE PRODUCING PSEUDOMONAS AERUGINOSA IN WOUNDS ABSTRACT Research Article Microbiology International Journal of Pharma and Bio Sciences ISSN 0975-6299 PHENOTYPIC DETECTION OF METALLO BETA LACTAMASE PRODUCING PSEUDOMONAS AERUGINOSA IN WOUNDS SANDHYA RANI T* 1

More information

Quality Control and Quality Assurance for Antibiotic Testing

Quality Control and Quality Assurance for Antibiotic Testing Quality assurance Quality Control and Quality Assurance for Antibiotic Testing 26 Sep 2013 Microbiology Technical Workshop Lily Ng Siew Yong practice of assessing performance in all steps of the process

More information

Nworu & Esimone. Division of Pharmaceutical Microbiology, Department of Pharmaceutics, University of Nigeria, Nsukka, , Enugu State

Nworu & Esimone. Division of Pharmaceutical Microbiology, Department of Pharmaceutics, University of Nigeria, Nsukka, , Enugu State Research Article Nworu & Esimone Tropical Journal of Pharmaceutical Research, December 2006; 5 (2): 605-611 Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria. All rights

More information

Effect of Storage of Mueller-Hinton Agar Plates on

Effect of Storage of Mueller-Hinton Agar Plates on APPUED MICROBIOLOGY, Sept. 1970, p. 293-297 Copyright 1970 American Society for Microbiology Vol. 20, No. 3 Printed in U.S.A. Effect of Storage of Mueller-Hinton Agar Plates on Zone Sizes for Antimicrobial

More information

Detection of aac(6 0 )-Ib-cr in KPC-producing Klebsiella pneumoniae isolates from Tel Aviv, Israel

Detection of aac(6 0 )-Ib-cr in KPC-producing Klebsiella pneumoniae isolates from Tel Aviv, Israel Journal of Antimicrobial Chemotherapy (2009) 64, 718 722 doi:10.1093/jac/dkp272 Advance Access publication 4 August 2009 Detection of aac(6 0 )-Ib-cr in KPC-producing Klebsiella pneumoniae isolates from

More information

Antibiotics. Disks for agar diffusion tests were purchased from Diagnostics Pasteur. Antibiotic powders were provided

Antibiotics. Disks for agar diffusion tests were purchased from Diagnostics Pasteur. Antibiotic powders were provided ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Nov. 1988, p. 1660-1665 0066-4804/88/111660-06$02.00/0 Copyright X 1988, American Society for Microbiology Vol. 32, No. 11 Comparative Study of a Novel Plasmid-Mediated

More information

Shionogi Presents Results of the First Clinical Efficacy Trial and In Vitro Data on Cefiderocol (S ), a Siderophore Cephalosporin

Shionogi Presents Results of the First Clinical Efficacy Trial and In Vitro Data on Cefiderocol (S ), a Siderophore Cephalosporin Shionogi Presents Results of the First Clinical Efficacy Trial and In Vitro Data on Cefiderocol (S-649266), a Siderophore Cephalosporin Osaka, Japan, April 22, 2017 - Shionogi & Co., Ltd. today announced

More information

Identification of Beta-Lactamase Enzymes and Prediction of Successful Beta-Lactam Therapy

Identification of Beta-Lactamase Enzymes and Prediction of Successful Beta-Lactam Therapy JOURNAL OF CLINICAL MICROBIOLOGY, May 1983, p. 791-798 95-1137/83/5791-8$2./ Copyright C 1983, American Society for Microbiology Vol. 17, No. 5 Relative Substrate Affinity Index Values: a Method for Identification

More information

Emergence of CMY-2- and DHA-1-type AmpC β-lactamases in Enterobacter cloacae isolated from several hospitals of Qazvin and Tehran, Iran

Emergence of CMY-2- and DHA-1-type AmpC β-lactamases in Enterobacter cloacae isolated from several hospitals of Qazvin and Tehran, Iran Volume 8 Number 3 (June 2016) 168-174 ORIGINAL ARTICLE Emergence of CMY-2- and DHA-1-type AmpC β-lactamases in Enterobacter cloacae isolated from several hospitals of and, Iran Amir Peymani, Taghi Naserpour-Farivar

More information

Abstract. Mary Jane Ferraro, PhD, MPH Jana M. Swenson, MMSc

Abstract. Mary Jane Ferraro, PhD, MPH Jana M. Swenson, MMSc January 2009 Vol. 29 No. 2 Replaces M07-A7 Vol. 26 No. 2 Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard Eighth Edition This document addresses

More information

Evaluation of a Rapid Bauer-Kirby Antibiotic Susceptibility

Evaluation of a Rapid Bauer-Kirby Antibiotic Susceptibility ANTIMICROBIAL AGENTS AND CHEMoTHERAPY, Mar. 1975. p. 250-255 Copyright 0 1975 American Society for Microbiology Vol. 7, No. 3 Printed in USA. Evaluation of a Rapid Bauer-Kirby Antibiotic Susceptibility

More information

Prevalence of Metallo- -Lactamases Producing Pseudomonas aeruginosa among the Clinical isolates: A study from tertiary care hospital

Prevalence of Metallo- -Lactamases Producing Pseudomonas aeruginosa among the Clinical isolates: A study from tertiary care hospital ISSN: 2319-7706 Volume 4 Number 4 (2015) pp. 955-961 http://www.ijcmas.com Original Research Article Prevalence of Metallo- -Lactamases Producing Pseudomonas aeruginosa among the Clinical isolates: A study

More information

Carbapenem Resistance in a Clinical Isolate of Enterobacter aerogenes Is Associated with Decreased Expression of OmpF and OmpC Porin Analogs

Carbapenem Resistance in a Clinical Isolate of Enterobacter aerogenes Is Associated with Decreased Expression of OmpF and OmpC Porin Analogs ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Dec. 2002, p. 3817 3822 Vol. 46, No. 12 0066-4804/02/$04.00 0 DOI: 10.1128/AAC.46.12.3817 3822.2002 Copyright 2002, American Society for Microbiology. All Rights

More information

Detection and characterization of extended-spectrum b-lactamases among bloodstream isolates of Enterobacter spp. in Hong Kong,

Detection and characterization of extended-spectrum b-lactamases among bloodstream isolates of Enterobacter spp. in Hong Kong, Journal of Antimicrobial Chemotherapy (2005) 55, 326 332 doi:10.1093/jac/dki010 Advance Access publication 28 January 2005 Detection and characterization of extended-spectrum b-lactamases among bloodstream

More information

Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories

Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories ORIGINAL ARTICLE BACTERIOLOGY Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories E. Matuschek 1, D. F. J. Brown

More information

Investigation of Klebsiella pneumoniae Isolates Producing SHV-12 and SHV-11 β-lactamases in Korean Hospitals

Investigation of Klebsiella pneumoniae Isolates Producing SHV-12 and SHV-11 β-lactamases in Korean Hospitals J. Microbiol. Biotechnol. (2009), 19(2), 000 000 doi: 10.4014/jmb.0808.472 First published online 3 June 2009 Investigation of Klebsiella pneumoniae Isolates Producing SHV-12 and SHV-11 β-lactamases in

More information

MICROORGANISM AND CHEMOTHERAPEIC MATERIALS

MICROORGANISM AND CHEMOTHERAPEIC MATERIALS MICROORGANISM AND CHEMOTHERAPEIC MATERIALS Chemotherapeutic substances are antimicrobials derived from chemical substances. Antibiotics are antimicrobials obtained from bacteria or fungi CHEMOTHERAPYTIC

More information

An extended-spectrum AmpC-type L-lactamase obtained by in vitro antibiotic selection

An extended-spectrum AmpC-type L-lactamase obtained by in vitro antibiotic selection FEMS Microbiology Letters 165 (1998) 85^90 An extended-spectrum AmpC-type L-lactamase obtained by in vitro antibiotic selection Mar èa-isabel Morosini a, Mar èa-cristina Negri a, Brian Shoichet b, Mar

More information

Introduction. Abstract. Journal of Scientific and Innovative Research 2014; 3 (1): Available online at:

Introduction. Abstract. Journal of Scientific and Innovative Research 2014; 3 (1): Available online at: Journal of Scientific and Innovative Research 214; 3 (1): 43-48 Available online at: www.jsirjournal.com Research Article ISSN 232-4818 JSIR 214; 3(1): 43-48 214, All rights reserved Received: 19-11-213

More information

First Report of a Providencia stuartii Strain Coproducing a Beta-Metalloenzyme NDM-1 Type and an Oxacillinase Type OXA-48

First Report of a Providencia stuartii Strain Coproducing a Beta-Metalloenzyme NDM-1 Type and an Oxacillinase Type OXA-48 760 International Journal of Collaborative Research on Internal Medicine & Public Health First Report of a Providencia stuartii Strain Coproducing a Beta-Metalloenzyme NDM-1 Type and an Oxacillinase Type

More information

Case Report First Description of KPC-2-Producing Klebsiella oxytoca Isolated from a Pediatric Patient with Nosocomial Pneumonia in Venezuela

Case Report First Description of KPC-2-Producing Klebsiella oxytoca Isolated from a Pediatric Patient with Nosocomial Pneumonia in Venezuela Case Reports in Infectious Diseases, Article ID 434987, 4 pages http://dx.doi.org/10.1155/2014/434987 Case Report First Description of KPC-2-Producing Klebsiella oxytoca Isolated from a Pediatric Patient

More information

Supplementary appendix

Supplementary appendix Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Quan J, Li X, Chen Y, et al. Prevalence of

More information

6/21/2012 Speaker Hannah Wexler, PhD, Objectives Continuing Education Credit program and evaluation by 07/21/ an Archived Program 612an

6/21/2012 Speaker Hannah Wexler, PhD, Objectives Continuing Education Credit program and evaluation by 07/21/ an Archived Program 612an Anaerobic Bacteria Susceptibility Testing 6/21/2012 Speaker Hannah Wexler, PhD, Adjunct Professor, Department of Medicine UCLA School of Medicine, Los Angeles, CA Dr. Hannah Wexler is an Adjunct Professor

More information

JAC Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 -lactamases

JAC Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 -lactamases Journal of Antimicrobial Chemotherapy (1999) 43, 23 29 JAC Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 -lactamases

More information

Incidence of Extended Spectrum Beta-lactamase Producing Pseudomonas Aeruginosa and Frequency of OXA-2 and OXA-10 Genes

Incidence of Extended Spectrum Beta-lactamase Producing Pseudomonas Aeruginosa and Frequency of OXA-2 and OXA-10 Genes Australian Journal of Basic and Applied Sciences, 4(8): 3202-3207, 2010 ISSN 1991-8178 Incidence of Extended Spectrum Beta-lactamase Producing Pseudomonas Aeruginosa and Frequency of OXA-2 and OXA-10 Genes

More information

ORIGINAL ARTICLE /j x

ORIGINAL ARTICLE /j x ORIGINAL ARTICLE 10.1111/j.1469-0691.2008.02030.x Metallo-b-lactamase-producing Pseudomonas aeruginosa isolated from a large tertiary centre in Kenya J. D. D. Pitout 1,2,3, G. Revathi 4, B. L Chow 1, B.

More information

Evaluation of Use of a New Chromogenic Agar in Detection of Urinary Tract Pathogens

Evaluation of Use of a New Chromogenic Agar in Detection of Urinary Tract Pathogens JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 1998, p. 990 994 Vol. 36, No. 4 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology Evaluation of Use of a New Chromogenic Agar in Detection of

More information

Transferable Cefoxitin Resistance in Enterobacteria from Greek Hospitals and Characterization of a Plasmid-Mediated Group 1 -Lactamase (LAT-2)

Transferable Cefoxitin Resistance in Enterobacteria from Greek Hospitals and Characterization of a Plasmid-Mediated Group 1 -Lactamase (LAT-2) ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, July 1996, p. 1736 1740 Vol. 40, No. 7 0066-4804/96/$04.00 0 Copyright 1996, American Society for Microbiology Transferable Cefoxitin Resistance in Enterobacteria

More information

Prevalence and spread of extendedspectrum b-lactamase-producing Enterobacteriaceae in Ngaoundere, Cameroon. Abstract. Editor: R.

Prevalence and spread of extendedspectrum b-lactamase-producing Enterobacteriaceae in Ngaoundere, Cameroon. Abstract. Editor: R. RESEARCH NOTE BACTERIOLOGY Prevalence and spread of extendedspectrum b-lactamase-producing Enterobacteriaceae in Ngaoundere, Cameroon C. Lonchel Magoue 1, P. Melin 1, J. Gangoue-Pieboji 2, M.-C. Okomo

More information

Comparative in-vitro activity of cefaclor against urinary tract isolates of Escherichia coli

Comparative in-vitro activity of cefaclor against urinary tract isolates of Escherichia coli Journal of Antimicrobial Chemotherapy (1996) 38, 59-66 Comparative in-vitro activity of cefaclor against urinary tract isolates of Escherichia coli C. A. Webster,. Curran and K. J. Towner* Department of

More information

Prevention of Transmission of the Superbug Carbapenem-Resistant Enterobacteriaceae (CRE) during Gastrointestinal Endoscopy

Prevention of Transmission of the Superbug Carbapenem-Resistant Enterobacteriaceae (CRE) during Gastrointestinal Endoscopy Prevention of Transmission of the Superbug Carbapenem-Resistant Enterobacteriaceae (CRE) during Gastrointestinal Endoscopy Sponsored by: Presentation by: Lawrence F. Muscarella, Ph.D. President LFM Healthcare

More information

Saudi Journal of Pathology and Microbiology. DOI: /sjpm ISSN (Print)

Saudi Journal of Pathology and Microbiology. DOI: /sjpm ISSN (Print) DOI:10.21276/sjpm.2016.1.2.6 Saudi Journal of Pathology and Microbiology Scholars Middle East Publishers Dubai, United Arab Emirates Website: http://scholarsmepub.com/ ISSN 2518-3362 (Print) ISSN 2518-3370

More information

Antimicrobial Susceptibility Testing of Acinetobacter spp. by NCCLS Broth Microdilution and Disk Diffusion Methods

Antimicrobial Susceptibility Testing of Acinetobacter spp. by NCCLS Broth Microdilution and Disk Diffusion Methods JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 2004, p. 5102 5108 Vol. 42, No. 11 0095-1137/04/$08.00 0 DOI: 10.1128/JCM.42.11.5102 5108.2004 Antimicrobial Susceptibility Testing of Acinetobacter spp. by NCCLS

More information

Use of Pharmacodynamic Indices To Predict Efficacy of Combination Therapy In Vivo

Use of Pharmacodynamic Indices To Predict Efficacy of Combination Therapy In Vivo ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 1999, p. 2473 2478 Vol. 43, No. 10 0066-4804/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Use of Pharmacodynamic Indices

More information

Is There Any Future for Inhibitors of Bacterial Cell Wall Biosynthesis? Karen Bush 21 May 2013

Is There Any Future for Inhibitors of Bacterial Cell Wall Biosynthesis? Karen Bush 21 May 2013 Is There Any Future for Inhibitors of Bacterial Cell Wall Biosynthesis? Karen Bush 21 May 2013 21 May 2013 1 Disclosures (2012-2013) Retiree: Johnson & Johnson, Pfizer (Wyeth), Bristol-Myers Squibb Consultant

More information

EM021. Co-Trimoxazole Ezy MIC TM Strip (COT)( mcg/ml) (Trimethoprim/ Sulphamethoxazole) Antimicrobial Susceptibility Testing

EM021. Co-Trimoxazole Ezy MIC TM Strip (COT)( mcg/ml) (Trimethoprim/ Sulphamethoxazole) Antimicrobial Susceptibility Testing Co-Trimoxazole Ezy MIC TM Strip (COT)(0.002-32 mcg/ml) (Trimethoprim/ Sulphamethoxazole) Antimicrobial Susceptibility Testing For In Vitro Diagnostic use EM021 Not for Medicinal Use It is a unique MIC

More information